{"disease":{"id":"idiopathic-inflammatory-myopathies","name":"idiopathic inflammatory myopathies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07077304","title":"EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05879419","title":"Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2005,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT07333196","title":"Tongji NADs Cohort","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1550,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT00055055","title":"Study of Families With Twins or Siblings Discordant for Rheumatic Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":1056,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT06306547","title":"Clinical Study Cohort of Idiopathic Inflammatory Myositis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT00341679","title":"Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":719,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT07087912","title":"Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":477,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT04664465","title":"PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT06665256","title":"Phase 2 Study of Rapcabtagene Autoleucel in Myositis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":123,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03897803","title":"Elastography in Patients With Idiopathic Inflammatory Myopathies","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Benha University","has_results":false},{"nct_id":"NCT06350110","title":"Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Essen Biotech","has_results":false},{"nct_id":"NCT06916806","title":"A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04792931","title":"Adult Autoimmune Myopathies (MAIA)","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT05199246","title":"Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Institut de Myologie, France","has_results":false},{"nct_id":"NCT04034199","title":"Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Kwong Wah Hospital","has_results":false},{"nct_id":"NCT07331272","title":"A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":38,"lead_sponsor_name":"Nanjing Legend Biotech Co.","has_results":false},{"nct_id":"NCT04561557","title":"Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05200702","title":"Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Institut de Myologie, France","has_results":false},{"nct_id":"NCT07295847","title":"A Study of AZD0120 in Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07022197","title":"Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT07527936","title":"A Study of BEN301 Injection in theTreatment of Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT06548607","title":"Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Nanjing Bioheng Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT03267277","title":"Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":true},{"nct_id":"NCT06970951","title":"Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"PersonGen BioTherapeutics (Suzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT04208464","title":"JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"University of Manchester","has_results":false},{"nct_id":"NCT07526350","title":"MTS109 in Patients With Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false},{"nct_id":"NCT06986018","title":"Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06549296","title":"Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"SUSPENDED","enrollment_count":12,"lead_sponsor_name":"Nanjing Bioheng Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT07315087","title":"CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06361745","title":"Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"PersonGen BioTherapeutics (Suzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT06417398","title":"Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"PersonGen BioTherapeutics (Suzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT06479863","title":"Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Austin Neuromuscular Center","has_results":false},{"nct_id":"NCT05400889","title":"Clinical Characteristics and Mechanism Research of Inhibitors of Janus Kinase in the Idiopathic Inflammatory Myopathies","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT07526493","title":"Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT07193810","title":"A Study of CC312 for Relapsed/Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"CytoCares Inc","has_results":false},{"nct_id":"NCT03918356","title":"Application of Electrical Impedance Myography (EIM) as a Potential Biomarker of Idiopathic Inflammatory Myopathies","phase":"NA","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT06524687","title":"A Study of Imvotamab in Active, Refractory Idiopathic Inflammatory Myopathies","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"IGM Biosciences, Inc.","has_results":false}],"total":37},"guidelines":[],"source":"Drug Landscape verified database"}